hERG-LTN:使用神经符号和生成AI预测hERG心脏毒性的新范式
概括
这项研究引入了一种新的AI模型,用于预测hERG通道抑制,这是药物安全的关键因素. 神经象征性AI方法增强了对心脏毒性的评估,提高了药物开发中的精确药物基因组学.
科学领域:
- 药物基因组学 药物基因组学
- 计算化学的计算化学
- 人工智能的人工智能
背景情况:
- 评估药物不良反应 (ADR) 对药物安全至关重要.
- hERG通道阻塞显著影响心脏再极化,并可能导致心脏毒性.
- 预测hERG抑制的现有计算方法存在局限性.
研究的目的:
- 开发一个强大的,基于推理的,in-silico模型来预测药物诱导的hERG抑制.
- 通过弥合hERG心脏毒性评估中的数据和知识差距,推进精确的药物基因组学.
- 通过减少与预测hERG心脏毒性相关的时间和成本来促进药物开发.
主要方法:
- 构建了UnihERG_DB数据集,其中有20409个药物样本被标记为hERG抑制.
- 使用摩根和CDK指纹提取了分子特征,并探索了LLM嵌入 (MegaMolBART,LLaMA,Gemini,DeepSeek).
- 利用逻辑 Tensor 网络 (LTN) 框架进行模型培训和开发.
主要成果:
- 与几种最先进的 (SOTA) 方法相比,hERG-LTN模型表现出更高的性能.
- 在外部测试-1数据集上实现了高精度 (0.931),特异性 (0.928) 和灵敏度 (0.933).
- 在hERG-70基准上获得了0.827的精度和0.890的特异性.
结论:
- 神经象征性AI方法为hERG心脏毒性评估建立了新的基准.
- 该模型提供了与当前SOTA模型相比具有竞争力的结果.
- 这种方法具有很大的潜力,可以在药物发现和开发中推进精确的药物基因组学.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
01:23Cardiopulmonary Resuscitation III: AED Use
489
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
489